Login / Signup

Acid- and Base-Mediated Hydrolysis of Dichloroacetamide Herbicide Safeners.

Monica E McFaddenEric V PattersonKeith P ReberIan W GilbertJohn D SiveyGregory H LeFevreDavid M Cwiertny
Published in: Environmental science & technology (2021)
Safeners are used extensively in commercial herbicide formulations. Although safeners are regulated as inert ingredients, some of their transformation products have enhanced biological activity. Here, to fill gaps in our understanding of safener environmental fate, we determined rate constants and transformation products associated with the acid- and base-mediated hydrolysis of dichloroacetamide safeners AD-67, benoxacor, dichlormid, and furilazole. Second-order rate constants for acid- (HCl) and base-mediated (NaOH) dichloroacetamide hydrolysis (2.8 × 10 -3 to 0.46 and 0.3-500 M -1 h -1 , respectively) were, in many cases (5 of 8), greater than those reported for their chloroacetamide herbicide co-formulants. In particular, the rate constant for base-mediated hydrolysis of benoxacor was 2 orders of magnitude greater than that of its active ingredient co-formulant, S -metolachlor. At circumneutral pH, only benoxacor underwent appreciable hydrolysis (5.3 × 10 -4 h -1 ), and under high-pH conditions representative of lime-soda softening, benoxacor's half-life was 13 h─a timescale consistent with partial transformation during water treatment. Based on Orbitrap LC-MS/MS analysis of dichloroacetamide hydrolysis product mixtures, we propose structures for major products and three distinct mechanistic pathways that depend on the system pH and compound structure. These include base-mediated amide cleavage, acid-mediated amide cleavage, and acid-mediated oxazolidine ring opening. Collectively, this work will help to identify systems in which hydrolysis contributes to the transformation of dichloroacetamides, while also highlighting important differences in the reactivity of dichloroacetamides and their active chloroacetamide co-formulants.
Keyphrases
  • anaerobic digestion
  • high resolution
  • ionic liquid
  • risk assessment
  • combination therapy
  • smoking cessation